MARKET

SLS

SLS

Sellas Life Sciences Group Inc
NASDAQ
4.100
-0.900
-18.00%
After Hours: 4.030 -0.07 -1.71% 19:13 01/06 EST
OPEN
4.980
PREV CLOSE
5.00
HIGH
5.05
LOW
3.620
VOLUME
26.94M
TURNOVER
--
52 WEEK HIGH
5.18
52 WEEK LOW
0.8505
MARKET CAP
584.01M
P/E (TTM)
-14.2857
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 9h ago
Weekly Report: what happened at SLS last week (1229-0102)?
Weekly Report · 1d ago
Catalyst Watch: AI spotlight at CES, Versant starts trading, and the December jobs report
Seeking Alpha · 4d ago
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 4d ago
Ironwood Pharmaceuticals, Baidu, Vertiv Holdings And Other Big Stocks Moving Higher On Friday
Benzinga · 4d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 4d ago
Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX?
NASDAQ · 4d ago
Why Baidu Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 4d ago
More
About SLS
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of therapeutics for a range of cancer indications. The Company's product candidates are galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor. GPS is a cancer immunotherapeutic agent licensed by Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed by GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of mainland China, Hong Kong, Macau, and Taiwan.

Webull offers Sellas Life Sciences Group Inc stock information, including NASDAQ: SLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLS stock methods without spending real money on the virtual paper trading platform.